XML 230 R95.htm IDEA: XBRL DOCUMENT v3.22.0.1
Interests in unconsolidated structured entities (Tables)
12 Months Ended
Dec. 31, 2021
Entity [Table]  
Disclosure Of Interests In Unconsolidated Structured Entities Explanatory
Interests in unconsolidated structured entities
31.12.21
USD million, except where indicated
Securitization
vehicles
Client
vehicles
Investment
funds
Total
Maximum
exposure to loss
1
Financial assets at fair value held for trading
246
162
6,743
7,151
7,151
Derivative financial instruments
5
45
155
205
205
Loans and advances to customers
125
125
125
Financial assets at fair value not held for trading
35
222
257
257
Financial assets measured at fair value through other comprehensive
 
income
324
4,525
4,849
4,849
Other financial assets measured at amortized cost
0
2
0
1
250
Total assets
610
3
4,732
7,247
12,588
Derivative financial instruments
2
11
281
294
Total liabilities
2
11
281
294
Assets held by the unconsolidated structured entities in which UBS had
 
an interest
(USD billion)
30
4
81
5
158
6
31.12.20
USD million, except where indicated
Securitization
vehicles
Client
vehicles
Investment
funds
Total
Maximum
exposure to loss
1
Financial assets at fair value held for trading
375
131
7,595
8,101
8,101
Derivative financial instruments
6
49
158
213
211
Loans and advances to customers
179
179
179
Financial assets at fair value not held for trading
35
1
2
172
208
208
Financial assets measured at fair value through other comprehensive
 
income
6,624
6,624
6,624
Other financial assets measured at amortized cost
0
2
0
250
Total assets
416
3
6,805
8,104
15,326
Derivative financial instruments
3
11
376
390
0
Total liabilities
3
11
376
390
Assets held by the unconsolidated structured entities in which UBS had
 
an interest
(USD billion)
39
4
136
5
124
6
1 For the purpose of this disclosure, maximum exposure to loss amounts do not consider the risk-reducing effects of collateral or other credit enhancements.
 
2 Represents the carrying amount of loan commitments.
The maximum exposure to loss for these instruments is equal
 
to the notional amount.
 
3 As of 31 December 2021, USD
0.1
 
billion of the USD
0.6
 
billion (31 December 2020: USD
0.2
 
billion of the USD
0.4
 
billion)
was held in Group Functions – Non-core and Legacy Portfolio.
 
4 Represents the principal
 
amount outstanding.
 
5 Represents the market value of total assets.
 
6 Represents the net asset value of the investment
funds sponsored by
 
UBS and the
 
carrying amount
 
of UBS’s
 
interests in the
 
investment funds not
 
sponsored by UBS.
 
In 2021,
 
UBS updated the
 
presentation of this
 
table to remove
 
its interests in
 
unconsolidated
structured investment funds and
 
the corresponding total asset
 
information, where UBS’s
 
interest is driven
 
solely from UBS’s
 
role as the
 
fund’s investment
 
manager and the fees
 
it receives. This
 
information is now
separately disclosed in the accompanying text on the following page. Prior-period
 
information has been aligned with this new presentation.
UBS AG  
Entity [Table]  
Disclosure Of Interests In Unconsolidated Structured Entities Explanatory
Interests in unconsolidated structured entities
31.12.21
USD million, except where indicated
Securitization
vehicles
Client
vehicles
Investment
funds
Total
Maximum
exposure to loss
1
Financial assets at fair value held for trading
246
162
6,743
7,151
7,151
Derivative financial instruments
5
45
155
205
205
Loans and advances to customers
125
125
125
Financial assets at fair value not held for trading
35
100
135
135
Financial assets measured at fair value through other comprehensive
 
income
324
4,525
4,849
4,849
Other financial assets measured at amortized cost
0
2
0
1
250
Total assets
610
3
4,732
7,124
12,466
Derivative financial instruments
2
11
281
294
Total liabilities
2
11
281
294
Assets held by the unconsolidated structured entities in which UBS AG had
 
an
interest (USD billion)
30
4
81
5
103
6
31.12.20
USD million, except where indicated
Securitization
vehicles
Client
vehicles
Investment
funds
Total
Maximum
exposure to loss
1
Financial assets at fair value held for trading
375
131
7,595
8,101
8,101
Derivative financial instruments
6
49
158
213
211
Loans and advances to customers
179
179
179
Financial assets at fair value not held for trading
35
1
2
73
109
109
Financial assets measured at fair value through other comprehensive
 
income
6,624
6,624
6,624
Other financial assets measured at amortized cost
0
2
0
250
Total assets
416
3
6,805
8,005
15,227
Derivative financial instruments
3
11
376
390
0
Total liabilities
3
11
376
390
Assets held by the unconsolidated structured entities in which UBS AG had
 
an
interest (USD billion)
39
4
136
5
89
6
1 For the purpose of this disclosure, maximum exposure to loss amounts do not consider the risk-reducing effects of collateral or other credit enhancements.
 
2 Represents the carrying amount of loan commitments.
The maximum exposure to loss for these instruments is equal
 
to the notional amount.
 
3 As of 31 December 2021, USD
0.1
 
billion of the USD
0.6
 
billion (31 December 2020: USD
0.2
 
billion of the USD
0.4
 
billion)
was held in Group Functions – Non-core and Legacy Portfolio.
 
4 Represents the principal amount outstanding.
 
5 Represents the market value of total assets.
 
6 Represents the net asset value of the investment
funds sponsored by
 
UBS AG and
 
the carrying amount
 
of UBS AG’s
 
interests in the
 
investment funds
 
not sponsored by
 
UBS AG.
 
In 2021, UBS
 
AG updated
 
the presentation of
 
this table to
 
remove its interests
 
in
unconsolidated structured investment funds and the corresponding total asset information, where UBS AG’s
 
interest is driven solely from UBS AG’s role as the fund’s
 
investment manager and the fees it receives. This
information is now separately disclosed in the accompanying text on the following page. Prior-period
 
information has been aligned with this new presentation.